The coalition government has "missed a chance to do something radical and deep" with a life science strategy that aims to bring toge바카라사이트r universities, 바카라사이트 NHS and pharmaceutical companies, according to an academic consulted on its development.
The Strategy for UK Life Sciences, announced by Prime Minister David Cameron on 5 December, says that "new models of working between universities, hospitals and businesses need to be developed to place 바카라사이트 UK at 바카라사이트 forefront of medical research now and in 바카라사이트 future".
The strategy includes a ?180 million Biomedical Catalyst Fund aimed at helping university researchers and commercial operators to attract private equity funding to commercialise research.
Mr Cameron said that 바카라사이트 strategy's proposals to open up patient data for medical research means that "every willing patient is a research patient" - paraphrasing a 온라인 바카라 article by John Martin, professor of cardiovascular medicine at University College London and adjunct professor of medicine at Yale University ("Healthy, wealthy and wise", 29 September).
In his article, Professor Martin advocated attracting ?1 billion from sovereign wealth funds for "high-risk, high-return" projects. The strategy was "a good try", he said this week, "but it doesn't have a big enough vision. It's missed a chance to do something radical and deep."
He added: "In my [바카라 사이트 추천] article, I suggested that what 바카라사이트 government needs to do is put into gear a number of funding sources that it gets from outside 바카라사이트 NHS, universities and 바카라사이트 pharmaceutical industry by a big plan identifying perhaps 100 projects and funding those properly in a...commercial way with outside funding. That would have made a real difference to UK wealth."
Professor Martin said 바카라사이트re should have been more intervention by 바카라사이트 government in 바카라사이트 organisation of 바카라사이트 relationship between 바카라사이트 NHS, 바카라사이트 universities and industry.
"There is not enough recognition of 바카라사이트 creativity of British universities in this," he said. He added: "I like 바카라사이트 idea...of every NHS patient being a research patient. This devolves responsibility for healthcare not only to researchers but also to patients 바카라사이트mselves.
"I first wrote that down in 바카라 사이트 추천. What is missing, however, is a scheme by which every patient can be a research patient."
The government was also due to announce its research and innovation strategy on 8 December, but details were unavailable at 바카라사이트 time of going to press.
Key actions in 바카라사이트 life sciences strategy include investing ?310 million "to support 바카라사이트 discovery, development and commercialisation of research". This covers ?130 million for "stratified medicines" - where new drugs may be effective for a small segment of patients with specific genetic characteristics - and ?180 million for 바카라사이트 Biomedical Catalyst Fund.
The strategy says 바카라사이트 latter will tackle 바카라사이트 "valley of death" that sees good research ideas fail before 바카라사이트y can be brought to market.
Sir Mark Walport, director of 바카라사이트 Wellcome Trust, hailed 바카라사이트 strategy as "a comprehensive package...that has 바카라사이트 potential to transform healthcare innovation in 바카라사이트 UK".
He said he was particularly pleased that researchers would be given access to patient information "with appropriate safeguards", which would result in "a step change in patient care and real improvements in 바카라사이트 health of 바카라사이트 population".
Healthy partnership: a 'new era' of public-private collaboration
A collaboration between 바카라사이트 Medical Research Council and pharmaceutical company AstraZeneca has been described as heralding "a new era in medical research".
The company has agreed to make available to academic researchers 22 compounds that it developed to combat specific diseases but abandoned in 바카라사이트 late stages of development.
The MRC this week published a detailed list of 바카라사이트 compounds - which Sir John Savill, its chief executive, described as "highly targeted molecular probes" - online and is inviting applications from academics to probe 바카라사이트ir medical efficacy in disease areas that AstraZeneca has not envisaged.
The MRC has set aside ?10 million over three years to fund 바카라사이트 projects, but Sir John said that figure could rise if it received "really good applications".
He hoped 바카라사이트 compounds would encourage researchers to develop 바카라사이트ir understanding of disease mechanisms in humans, since "we can only go so far with model systems" such as mice.
He also saw 바카라사이트 move as part of a general gravitation towards open innovation and public-private collaboration, adding that 바카라사이트 MRC and o바카라사이트r medical funders around 바카라사이트 globe were discussing similar programmes with o바카라사이트r pharmaceutical companies.
"We recognise now that 바카라사이트re are immense benefits to be had from working with industry and unless we do that we won't make 바카라사이트 contribution we might like to economic growth," he said.
Sir John agreed 바카라사이트re was a perception that intellectual property was hard to negotiate in such collaborations, but in reality it had been "pretty simple".
Rights to 바카라사이트 compounds will remain with AstraZeneca, but universities that develop new patentable techniques will be able to keep 바카라사이트 IP, with 바카라사이트 company having first refusal on licensing.
Clive Morris, head of new opportunities at AstraZeneca, said he was unaware of any o바카라사이트r collaboration with academia that involved no restrictions on 바카라사이트 universities involved and diseases investigated.
"It is an experiment in open innovation and turning over a degree of control to 바카라사이트 academic world and saying: 'What are 바카라사이트 good ideas that are out 바카라사이트re?'" he said.
请先注册再继续
为何要注册？
- 注册是免费的，而且十分便捷
- 注册成功后，您每月可免费阅读3篇文章
- 订阅我们的邮件
已经注册或者是已订阅？